https://orcid.org/0000-0003-2839-7305
References
- Cheng Y, Li T, Zheng Y, Xu B, Bi Y, Hu Y, Zhou YH. Self-Reported adverse events among Chinese healthcare workers immunized with COVID-19 vaccines composed of inactivated SARS-CoV-2. Hum Vaccin Immunother. 2022:1–2. doi:10.1080/21645515.2022.2064134.
- Finsterer J, Scorza FA, Scorza CA. Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients. Clinics (Sao Paulo). 2021;76:e3286. doi:10.6061/clinics/2021/e3286.
- Tutar NK, Eyigürbüz T, Yildirim Z, Kale N. A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN. Ideggyogy Sz. 2021;74(7–08):286–288. doi:10.18071/isz.74.0286.
- Finsterer J. Neurological side effects of SARS-CoV-2 vaccinations. Acta Neurol Scand. 2022;145(1):5–9. doi:10.1111/ane.13550.
- Wang G, Zhu L, Zhu Y, Ye Q, Yu X, Fu M, Lu J, Li X, Huang Y, Zhang J, et al. Safety survey by clinical pharmacists on COVID-19 vaccination from a single center in China. Hum Vaccin Immunother. 2021;17(9):2863–2867. doi:10.1080/21645515.2021.1913964.